Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYDG.L Regulatory News (HYDG)

  • There is currently no data for HYDG

Half Year Update

2 Jul 2012 07:00

RNS Number : 5678G
Hydrogen Group PLC
02 July 2012
 



 

 

2 July 2012

Hydrogen Group plc

Half Year Update

Hydrogen Group plc ('Hydrogen' or the 'Group'), the global specialist recruitment business, is today issuing a trading update in respect of the six months ended 30 June 2012 (the 'period').

The Group continued to trade in line with expectations during the period despite the on-going macroeconomic uncertainty, delivering modest growth in Net Fee Income ('NFI') year on year.

Hydrogen continued to progress its strategy of growing a balanced business by carefully selecting and developing its presence in attractive geographies and markets. Group NFI generated from outside the UK increased to approximately 40% during the first six months and, as at the period end, more than 50% of client facing employees were servicing growth markets overseas. The Group renamed its Pharmaceuticals practice to Life Sciences, more accurately reflecting the increased scope of its activity, and together with Oil & Gas resulted in approximately 37% of Group NFI being generated from Technical & Scientific markets. The continued strong performance of these relatively new practices demonstrates Hydrogen's ability to identify new markets as well as its flexibility to deliver quickly on the significant growth opportunities they offer.

Ensuring Hydrogen has the correct infrastructure in place to facilitate long-term growth is a key strategic focus and the Group has continued to make good progress in this area during the period. The Group piloted its new cloud-based global customer relationship management system ("CRM") during the first six months and this will be rolled out across the rest of the business in the second half of the year. The Group also launched the rebrand of its individual UK brands under the Hydrogen brand. Together with the new CRM system this will deliver long-term competitive advantage by enabling Hydrogen to provide a more consistent global service to clients and candidates.

Commenting, Ian Temple, Executive Chairman said:

"Hydrogen has performed well in the first half of the year despite continued uncertainty in the global recruitment markets. We have continued to focus on our strategy of building global practices in our specialist markets and we remain well positioned for the long term.

The business continues to trade in line with our expectations. Nevertheless, on-going debt issues in Europe and the uncertain economic outlook mean that visibility across recruitment markets remains limited. The impact of the Olympic Games on UK recruitment markets in the second half of the year is unknown. However, we are confident in the performance of our international operations and contractor activity, and that the Group remains on target to achieve its 2012 goals."

Enquiries:

Hydrogen Group plc

020 7240 2500

Ian Temple, Executive Chairman

Tim Smeaton, Chief Executive

 

Hudson Sandler

020 7796 4133

Alex Brennan

 

Oriel Securities (NOMAD)

 

020 7710 7600

Nicholas How

Emma Griffin

 

Notes to Editors:

Hydrogen is a specialist recruitment business with a turnover in excess of £150m. We build relationships by finding specialist candidates our clients have difficulty sourcing, placing professionals in more than 50 countries.

Our joined-up practice teams combine international reach with local expertise and specialist knowledge, to provide visibility of world class candidates.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFIRRSIAFIF
Date   Source Headline
30th Oct 20157:00 amRNSTotal Voting Rights
2nd Oct 20152:12 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSTotal Voting Rights
15th Sep 20157:00 amRNSHalf Yearly Report
4th Sep 20157:00 amRNSNotice of Results
1st Sep 20157:03 amRNSTotal Voting Rights
3rd Aug 20157:00 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSBlocklisting Interim Review- Unapproved
8th Jul 20157:00 amRNSBlocklisting Interim Review - EMI
1st Jul 20154:51 pmRNSHolding(s) in Company
30th Jun 20152:31 pmRNSTotal Voting Rights
2nd Jun 20152:53 pmRNSDirector/PDMR Shareholding
29th May 20152:08 pmRNSTotal Voting Rights
21st May 20151:17 pmRNSResult of AGM
6th May 20157:02 amRNSAppointment of CFO
1st May 20159:35 amRNSTotal Voting Rights
13th Apr 20159:21 amRNSNotice of AGM
31st Mar 201511:23 amRNSTotal Voting Rights
9th Mar 20158:02 amRNSHolding(s) in Company
4th Mar 20157:00 amRNSFinal results year ended 31 Dec 14 & Board changes
2nd Mar 20158:57 amRNSTotal Voting Rights
2nd Feb 20159:21 amRNSTotal Voting Rights
20th Jan 20157:00 amRNSTrading Statement
8th Jan 20157:00 amRNSBlocklisting Interim Review
8th Jan 20157:00 amRNSBlocklisting Interim Review
31st Dec 20147:00 amRNSTotal Voting Rights
1st Dec 20148:59 amRNSTotal Voting Rights
18th Nov 201412:22 pmRNSHolding(s) in Company
3rd Nov 20147:00 amRNSTotal Voting Rights
1st Oct 20141:03 pmRNSHolding(s) in Company
1st Oct 201412:50 pmRNSTotal Voting Rights
17th Sep 20147:00 amRNSDirector's Share Dealing and Holding in Company
16th Sep 20147:00 amRNSUNAUDITED RESULTS FOR HALF YEAR ENDED 30 JUNE 2014
1st Sep 20149:00 amRNSTotal Voting Rights
4th Aug 20141:44 pmRNSTotal Voting Rights
22nd Jul 20147:00 amRNSTrading Statement
8th Jul 20149:24 amRNSBlock Listing Six Monthly Return - Unapproved
8th Jul 20149:19 amRNSBlock Listing Six Monthly Return
1st Jul 20143:06 pmRNSDirector/PDMR Shareholding
1st Jul 201412:47 pmRNSTotal Voting Rights
2nd Jun 20142:23 pmRNSHolding(s) in Company
2nd Jun 20142:12 pmRNSTotal Voting Rights
22nd May 20141:58 pmRNSResult of AGM
22nd May 20147:00 amRNSAGM Statement and Trading Update
8th May 20149:19 amRNSDirector/PDMR Shareholding
30th Apr 20144:45 pmRNSTotal Voting Rights
31st Mar 20144:00 pmRNSTotal Voting Rights
26th Mar 20148:24 amRNSDirector/PDMR Shareholding
17th Mar 20147:00 amRNSFinal Results
3rd Mar 201411:40 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.